Results 201 to 210 of about 17,288 (263)
Some of the next articles are maybe not open access.
DESMOPRESSIN AND ANTIFIBRINOLYTICS
International Anesthesiology Clinics, 1990Desmopressin appears to be a safe and effective hemostatic agent for use during surgery in patients with mild to moderate hemophilia or von Willebrand disease. Uremic patients also benefit from substitution of desmopressin for cryoprecipitate to control bleeding. The highly variable response to desmopressin by individual patients with hemophilia or von
openaire +2 more sources
Critical Care Medicine, 2019
OBJECTIVE Current international guidelines offer a conditional recommendation to consider a single dose of IV desmopressin (DDAVP) for antiplatelet-associated intracranial hemorrhage based on low-quality evidence.
E. Feldman +9 more
semanticscholar +1 more source
OBJECTIVE Current international guidelines offer a conditional recommendation to consider a single dose of IV desmopressin (DDAVP) for antiplatelet-associated intracranial hemorrhage based on low-quality evidence.
E. Feldman +9 more
semanticscholar +1 more source
Regulatory Peptides, 1993
Since it has been synthetized in 1967, desmopressin (Minirin) R or DDAVP (1-desamino-8-Darginine vasopressin) was initially used for its antidiuretic properties [1]. Its capacity to induce an increase in plasma level of procoagulant factor VIII C (FVIII C), von Willebrand factor (vWF) and plasminogen activator was recognized in the following years [2,3]
openaire +3 more sources
Since it has been synthetized in 1967, desmopressin (Minirin) R or DDAVP (1-desamino-8-Darginine vasopressin) was initially used for its antidiuretic properties [1]. Its capacity to induce an increase in plasma level of procoagulant factor VIII C (FVIII C), von Willebrand factor (vWF) and plasminogen activator was recognized in the following years [2,3]
openaire +3 more sources
OXYBUTYNIN, DESMOPRESSIN AND ENURESIS
The Journal of Urology, 2001A review of the scarce literature concerning oxybutynin treatment for nocturnal enuresis reveals that its success is greatest when enuresis is combined with daytime incontinence. The renal and bladder related characteristics of children with monosymptomatic enuresis responsive to oxybutynin were evaluated.Renal concentrating capacity and functional ...
openaire +3 more sources
Annals of Internal Medicine, 1988
Excerpt To the editor: Kobrinsky and associates (1) show that patients receiving 1-desamino-8-D-arginine vasopressin (desmopressin) had a decreased blood loss during Harrington rod spinal fusion su...
openaire +3 more sources
Excerpt To the editor: Kobrinsky and associates (1) show that patients receiving 1-desamino-8-D-arginine vasopressin (desmopressin) had a decreased blood loss during Harrington rod spinal fusion su...
openaire +3 more sources
The use of desmopressin in mild hemophilia A
Blood Coagulation & Fibrinolysis, 2010Owing to its ability to raise plasma levels of factor VIII and von Willebrand factor levels, the synthetic vasopressin analogue desmopressin has become the mainstay of treatment for type 1 von Willebrand disease and mild hemophilia A. A long clinical experience with this drug for prevention or treatment of bleedings in these patients has been ...
Franchini M., Zaffanello M., Lippi G.
openaire +3 more sources
BJU International, 2018
To assess the efficacy of desmopressin, alarm, desmopressin plus alarm, and desmopressin plus anticholinergic agent (AA) therapy in the management of paediatric monosymptomatic nocturnal enuresis (MNE) using a network meta‐analysis.
Pan Song +11 more
semanticscholar +1 more source
To assess the efficacy of desmopressin, alarm, desmopressin plus alarm, and desmopressin plus anticholinergic agent (AA) therapy in the management of paediatric monosymptomatic nocturnal enuresis (MNE) using a network meta‐analysis.
Pan Song +11 more
semanticscholar +1 more source
Desmopressin (DDAVP) and hemostasis
Annals of Hematology, 1994Desmopressin is a widely used hemostatic drug. It is a synthetic analogue of the natural hormone vasopressin, but, in contrast to vasopressin, it has no pressor activity. The effect is immediate, with two- to sixfold increases in the plasma concentrations of coagulation factor VIII, on Willebrand factor, and tissue plasminogen activator, and increases ...
openaire +3 more sources
Severe hyponatremia due to desmopressin
The Journal of Emergency Medicine, 2006Nasal desmopressin (DDAVP) is a commonly prescribed antidiuretic hormone (ADH) analogue used for treatment of diabetes insipidus, polyuria and nocturnal enuresis. Although it is generally well tolerated, it can cause severe electrolyte imbalance. Numerous reports exist on cases of mild to moderate DDAVP-induced hyponatremia, yet few reports describe ...
Sean O. Henderson, H. Brendan Kelleher
openaire +2 more sources
Therapeutic Drug Monitoring, 2019
Hemophilia A and B are hereditary bleeding disorders, caused by a deficiency of clotting factor VIII or clotting factor IX, respectively. To treat and prevent bleedings, patients can administer clotting factor concentrates (hemophilia A and B) or ...
T. Preijers +6 more
semanticscholar +1 more source
Hemophilia A and B are hereditary bleeding disorders, caused by a deficiency of clotting factor VIII or clotting factor IX, respectively. To treat and prevent bleedings, patients can administer clotting factor concentrates (hemophilia A and B) or ...
T. Preijers +6 more
semanticscholar +1 more source